“The US government has changed its procedural strategy in a lawsuit that challenges its funding of human embroynic stem cell research, agreeing with the plaintiffs that a lower court judge should receive additional briefings before deciding the case on its merits …” (more)
[Meredith Wadman, The Great Beyond, 18 May]